A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalized with COVID-19 pneumonia. A proof-of-concept trial led by the Universities…
Survey conducted in Germany, Austria, and Switzerland suggests that COVID-19 lockdown measures exacerbated chronic pain, particularly among women. COVID-19 lockdown measures appear to have had…
The pandemic has brought many tricky terms and ideas from epidemiology into everyone’s lives. Two particularly complicated concepts are vaccine efficacy and effectiveness. These are…
Viruses reproduce by taking over the replication machinery of host cells to make copies of their own genetic material, or genome. Unlike cellular organisms, whose…
An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3…
When animals catch COVID-19 from humans, new SARS-CoV-2 variants can arise. To evaluate this phenomenon, an interdisciplinary team at the College of Veterinary Medicine and…
COVID-19 may have spread faster in US because first symptom was cough. Study by USC researchers finds that order of symptoms in first wave of…
False positive reactivity in earliest RT-PCR tests due to contamination and design errors. The earliest batch of COVID-19 tests distributed by the US Centers for…
Now that kids ages 5 to 11 are eligible for COVID-19 vaccination and the number of fully vaccinated people in the U.S. is rising, many…
Kaiser Permanente study shows 2-dose Moderna vaccine is highly effective against COVID-19 hospitalization, but protection against delta infection decreases over time. Kaiser Permanente research…
Blood pressure control worsened in both men and women with the onset of the COVID-19 pandemic in the United States in 2020. Women and older…
A research team at Aarhus University has developed a new molecule that attaches to the surface of SARS-CoV-2 virus particles. This attachment prevents the virus…
Findings suggest way to help patients heal from dangerous C. difficile. New research from the University of Virginia School of Medicine sheds light on why…
NIH scientists developed vaccine platform. An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice…
A pair of over-the-counter compounds has been found in preliminary tests to inhibit the virus that causes COVID-19, University of Florida Health researchers have found….
Vaccines and previous infection could offer some “stronger than basic” protection to Omicron, early study suggests. Tube samples of Omicron, however, do further propose its…
A team of researchers at the MUSC Shawn Jenkins Children’s Hospital contributed to a nationwide study on the effectiveness of Pfizer-BioNTech’s COVID-19 vaccine against hospitalization…
Skoltech scientists and their colleagues have looked at the genetic makeup of the dominant strain of the coronavirus, the delta variant, in Russia. According to them, just one…